X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (257) 257
Publication (24) 24
Book / eBook (16) 16
Book Chapter (6) 6
Conference Proceeding (3) 3
Magazine Article (2) 2
Newspaper Article (2) 2
Book Review (1) 1
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (89) 89
humans (75) 75
male (65) 65
female (48) 48
adult (35) 35
animals (29) 29
middle aged (27) 27
aged (26) 26
infectious diseases (25) 25
neurosciences (25) 25
microbiology (20) 20
treatment outcome (20) 20
diagnosis (19) 19
analysis (17) 17
pharmacology & pharmacy (17) 17
research (17) 17
health aspects (16) 16
mice (16) 16
therapy (15) 15
dopamine (14) 14
risk factors (14) 14
care and treatment (13) 13
immunology (12) 12
microbial sensitivity tests (12) 12
oncology (12) 12
anti-bacterial agents - pharmacology (11) 11
hiv (11) 11
research article (11) 11
aged, 80 and over (10) 10
drug therapy, combination (10) 10
hematology (10) 10
italy (10) 10
medicine, research & experimental (10) 10
multidisciplinary sciences (10) 10
patients (10) 10
prognosis (10) 10
proteins (10) 10
adolescent (9) 9
anti-bacterial agents - therapeutic use (9) 9
basal ganglia (9) 9
biochemistry & molecular biology (9) 9
brain (9) 9
cardiac & cardiovascular systems (9) 9
medicine (9) 9
mice, inbred c57bl (9) 9
parkinson's disease (9) 9
prevalence (9) 9
signal transduction (9) 9
viruses (9) 9
activation (8) 8
drug therapy (8) 8
expression (8) 8
genetic aspects (8) 8
infections (8) 8
medical research (8) 8
movement disorders (8) 8
neuroscience (8) 8
psychiatry (8) 8
biochemical phenomena, metabolism, and nutrition (7) 7
cell survival - drug effects (7) 7
clinical neurology (7) 7
colistin (7) 7
corpus striatum - drug effects (7) 7
epidemiology (7) 7
follow-up studies (7) 7
lymphocytes (7) 7
mortality (7) 7
neurodegenerative diseases (7) 7
neurology (7) 7
public health (7) 7
virus diseases (7) 7
adenosine (6) 6
article subject (6) 6
biomarkers (6) 6
bone marrow (6) 6
cell biology (6) 6
flow cytometry (6) 6
gene expression (6) 6
guidelines (6) 6
haloperidol (6) 6
infection (6) 6
italy - epidemiology (6) 6
long-term potentiation (6) 6
management (6) 6
medicine & public health (6) 6
medicine, experimental (6) 6
medium spiny neurons (6) 6
pathogenesis (6) 6
patient outcomes (6) 6
phenols (6) 6
receptors (6) 6
science (6) 6
strains (6) 6
t cells (6) 6
time factors (6) 6
young adult (6) 6
abridged index medicus (5) 5
age (5) 5
age factors (5) 5
aids (5) 5
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, p. e0149601
HIV-infected patients appear to have a significantly greater risk of non-AIDS comorbidities such as osteoporosis and atherosclerosis. Subjects with... 
BIOMARKERS | ACTIVATION | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | VASCULAR CALCIFICATION | CARDIOVASCULAR-DISEASE | ATHEROSCLEROSIS | INFECTED PATIENTS | T-LYMPHOCYTES | OSTEOPOROSIS | IMMUNOSENESCENCE | Biomarkers - metabolism | Bone Diseases - epidemiology | Carotid Intima-Media Thickness | Comorbidity | HIV Infections - epidemiology | Humans | Middle Aged | Male | HIV Infections - immunology | Phenotype | Cardiovascular Diseases - diagnostic imaging | Cardiovascular Diseases - epidemiology | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Immunosenescence | Osteoprotegerin - metabolism | T-Lymphocytes - pathology | HIV Infections - metabolism | Osteoporosis | Complications and side effects | Prognosis | Demographic aspects | Atherosclerosis | Research | HIV infection | Risk factors | Therapy | Pathogenesis | CD8 antigen | Cardiovascular disease | Cell activation | Acquired immune deficiency syndrome--AIDS | Human immunodeficiency virus--HIV | Biocompatibility | Public health | Osteopenia | Antiretroviral drugs | Mortality | Regression analysis | Patients | Antiretroviral therapy | Infectious diseases | Bone mass | Correlation analysis | Arteriosclerosis | Calcification | Ligands | Plasma levels | Cardiovascular diseases | Senescence | Lymphocytes T | Infections | Activation | Bone diseases | Osteoprotegerin | Antiretroviral agents | Lymphocytes | Drug therapy | Ultrasound | Enzyme-linked immunosorbent assay | Age | Cardiovascular system | Dual energy X-ray absorptiometry | Immune response | Health risks | Inflammation | Vascular system | Cholesterol | CD4 antigen | Cytometry | Bone mineral density | Bone | Diabetes | Acquired immune deficiency syndrome | AIDS | Human immunodeficiency virus | HIV
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, p. e0160277
The anti-CD49d monoclonal antibody natalizumab is currently an effective therapy against the relapsing-remitting form of multiple sclerosis (RRMS). Natalizumab... 
ANTIBODIES | VIRUS-DNA | PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY | HUMAN POLYOMAVIRUS | MULTIDISCIPLINARY SCIENCES | RISK | STEADY-STATE | HUMAN-SERA | INFECTION | PREVALENCE | PML | Leukoencephalopathy, Progressive Multifocal - immunology | Multiple Sclerosis, Relapsing-Remitting - immunology | Multiple Sclerosis, Relapsing-Remitting - therapy | Humans | Natalizumab - adverse effects | Leukoencephalopathy, Progressive Multifocal - virology | DNA, Viral - analysis | Male | Treatment Outcome | JC Virus - physiology | Antibodies, Viral - blood | DNA, Viral - blood | Phenotype | Virus Activation - drug effects | Natalizumab - pharmacology | JC Virus - drug effects | T-Lymphocytes - drug effects | Adult | Female | T-Lymphocytes - immunology | Multiple Sclerosis, Relapsing-Remitting - virology | Leukoencephalopathy, Progressive Multifocal - complications | Multiple Sclerosis, Relapsing-Remitting - complications | Medical research | Multiple sclerosis | Analysis | Medicine, Experimental | Disease susceptibility | Genetic aspects | T cells | Health aspects | Leukocyte migration | CD8 antigen | Central nervous system | Effector cells | Lymphocytes T | Infections | Activation | Leukoencephalopathy | Blood | Accumulation | Progressive multifocal leukoencephalopathy | Genotype & phenotype | Cell activation | Lymphocytes | Peripheral blood | Bone marrow | Public health | Deoxyribonucleic acid--DNA | Urine | Anticoagulants | Antigens | Immunoglobulins | Memory cells | Statistical analysis | CD49d antigen | Immunosurveillance | Attorneys | Gene expression | CD4 antigen | Neurology | Infectious diseases | Relative abundance | Monoclonal antibodies | Psychiatry | Deoxyribonucleic acid | DNA
Journal Article
Journal Article
Journal Article
Mediators of Inflammation, ISSN 0962-9351, 2014, Volume 2014, pp. 192594 - 8
Journal Article
Journal of the International AIDS Society, ISSN 1758-2652, 10/2016, Volume 19, Issue 8(Suppl 7), pp. 21487 - n/a
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 16, pp. 1617 - 1629
Summary Background High-dose melphalan plus autologous stem-cell transplantation (ASCT) is the standard approach in transplant-eligible patients with newly... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | ONCOLOGY | CONSOLIDATION THERAPY | INITIAL TREATMENT | THALIDOMIDE | BORTEZOMIB | INDUCTION | STEM-CELL TRANSPLANTATION | DEXAMETHASONE COMBINATION | ELDERLY-PATIENTS | MELPHALAN | Multiple Myeloma - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Transplantation, Autologous | Melphalan - therapeutic use | Hematopoietic Stem Cell Transplantation - mortality | Cyclophosphamide - therapeutic use | Thalidomide - analogs & derivatives | Multiple Myeloma - therapy | Time Factors | Hematopoietic Stem Cell Transplantation - adverse effects | Female | Maintenance Chemotherapy | Chemotherapy, Adjuvant | Thalidomide - adverse effects | Prednisone - adverse effects | Multiple Myeloma - diagnosis | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Disease Progression | Disease-Free Survival | Czech Republic | Dexamethasone - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Italy | Aged | Thalidomide - therapeutic use | Australia | Prednisone - therapeutic use | Medical colleges | Cyclophosphamide | Care and treatment | Chemotherapy | Dexamethasone | Multiple myeloma | Stem cells | Product development | Prednisone | Transplantation | Cancer
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 09/2015, Volume 15, Issue 1, pp. 1 - 8
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2015, Volume 10, Issue 1, p. e0116468
Human mesenchymal stem cells (hMSCs), the precursors of osteoblasts during osteogenesis, play a role in the balance of bone formation and resorption, but their... 
CINACALCET | MULTIDISCIPLINARY SCIENCES | ALIZARIN RED-S | SECONDARY HYPERPARATHYROIDISM | HEMODIALYSIS-PATIENTS | MARKERS | MINERAL METABOLISM | CALCIFICATION | HYDROGEN-SULFIDE | BONE | EXPRESSION | Cell Survival - drug effects | Collagen Type I - metabolism | RANK Ligand - metabolism | Osteocalcin - metabolism | Humans | Osteogenesis - drug effects | Cells, Cultured | Solubility | Male | Osteopontin - metabolism | Cinacalcet - pharmacology | Case-Control Studies | Uremia - pathology | Cell Differentiation - drug effects | Culture Media | Uremia - blood | Bone Morphogenetic Protein 2 - metabolism | Hemofiltration | Mesenchymal Stem Cells - drug effects | Adult | Female | Osteoprotegerin - metabolism | Cellular Microenvironment - drug effects | Mesenchymal Stem Cells - metabolism | Hydrogen sulfide | Comparative analysis | Sulfates | Collagen | Stem cells | Regulators | Collagen (type I) | Nephrology | Hemodialysis | Cardiovascular disease | Biochemistry | Phosphatase | Osteoblasts | Alizarin | Glial stem cells | Proteins | Bone growth | Mineralization | Bone marrow | Biocompatibility | Internal medicine | Osteopontin | Cultures | Metabolism | Patients | Pathology | Parathyroid hormone | Calcification | Dialysis | Toxins | Sulfide | Osteoprogenitor cells | Adaptive systems | Calcium | Mesenchyme | Osteoprotegerin | Bone resorption | Biomedical materials | Reduction | Tumor necrosis factor-TNF | TRANCE protein | Parathyroid | Osteocalcin | Bone morphogenetic protein 2 | Bone remodelling | Biophysics | Medicine | Kidney diseases | Bone | Sulfate | Uremia | Homocysteine | Osteogenesis
Journal Article